ANTIVIRAL NUCLEOSIDE ANALOGUES

Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARTIN,MICHAEL TOLAR, DRACH,JOHN CHARLES, TOWNSEND,LEROY B, GOOD,STEVEN SPENCER, DALUGE,SUSAN MARY
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	MARTIN,MICHAEL TOLAR DRACH,JOHN CHARLES TOWNSEND,LEROY B GOOD,STEVEN SPENCER DALUGE,SUSAN MARY
description	Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUT68445A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUT68445A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUT68445A3</originalsourceid><addsrcrecordid>eNrjZJBz9AvxDPMMcvRR8At19nH1D_Z0cVVw9HP08XcPdQ3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxHqEhZhYmJqaOxgQVAAAOKyCp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIVIRAL NUCLEOSIDE ANALOGUES</title><source>esp@cenet</source><creator>MARTIN,MICHAEL TOLAR ; DRACH,JOHN CHARLES ; TOWNSEND,LEROY B ; GOOD,STEVEN SPENCER ; DALUGE,SUSAN MARY</creator><creatorcontrib>MARTIN,MICHAEL TOLAR ; DRACH,JOHN CHARLES ; TOWNSEND,LEROY B ; GOOD,STEVEN SPENCER ; DALUGE,SUSAN MARY</creatorcontrib><description>Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.</description><edition>5</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19950628&DB=EPODOC&CC=HU&NR=T68445A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19950628&DB=EPODOC&CC=HU&NR=T68445A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARTIN,MICHAEL TOLAR</creatorcontrib><creatorcontrib>DRACH,JOHN CHARLES</creatorcontrib><creatorcontrib>TOWNSEND,LEROY B</creatorcontrib><creatorcontrib>GOOD,STEVEN SPENCER</creatorcontrib><creatorcontrib>DALUGE,SUSAN MARY</creatorcontrib><title>ANTIVIRAL NUCLEOSIDE ANALOGUES</title><description>Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBz9AvxDPMMcvRR8At19nH1D_Z0cVVw9HP08XcPdQ3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxHqEhZhYmJqaOxgQVAAAOKyCp</recordid><startdate>19950628</startdate><enddate>19950628</enddate><creator>MARTIN,MICHAEL TOLAR</creator><creator>DRACH,JOHN CHARLES</creator><creator>TOWNSEND,LEROY B</creator><creator>GOOD,STEVEN SPENCER</creator><creator>DALUGE,SUSAN MARY</creator><scope>EVB</scope></search><sort><creationdate>19950628</creationdate><title>ANTIVIRAL NUCLEOSIDE ANALOGUES</title><author>MARTIN,MICHAEL TOLAR ; DRACH,JOHN CHARLES ; TOWNSEND,LEROY B ; GOOD,STEVEN SPENCER ; DALUGE,SUSAN MARY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUT68445A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MARTIN,MICHAEL TOLAR</creatorcontrib><creatorcontrib>DRACH,JOHN CHARLES</creatorcontrib><creatorcontrib>TOWNSEND,LEROY B</creatorcontrib><creatorcontrib>GOOD,STEVEN SPENCER</creatorcontrib><creatorcontrib>DALUGE,SUSAN MARY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARTIN,MICHAEL TOLAR</au><au>DRACH,JOHN CHARLES</au><au>TOWNSEND,LEROY B</au><au>GOOD,STEVEN SPENCER</au><au>DALUGE,SUSAN MARY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIVIRAL NUCLEOSIDE ANALOGUES</title><date>1995-06-28</date><risdate>1995</risdate><abstract>Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_HUT68445A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	ANTIVIRAL NUCLEOSIDE ANALOGUES
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A36%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARTIN,MICHAEL%20TOLAR&rft.date=1995-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUT68445A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true